GlassScriptPhysician profile
Daniel Kiss
NPI 1124311642
$172,369.59
in general payments reported to CMS, 2019-2025
36 companies · $71K in 2025
The $71K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,267 · 2020: $759 · 2021: $9,907 · 2022: $13K · 2023: $23K · 2024: $53K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $71K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $41K · Travel and Lodging: $21K · Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $70,625.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $40,700.00 |
| Travel and Lodging | $21,306.40 |
| Food and Beverage | $11,644.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $82,884.64 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $77,561.95 | 2019-2025 | Optis, Dragonfly Opstar, Mitraclip |
| Medtronic, INC. | $4,031.97 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Edwards Lifesciences Corporation | $1,933.28 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $1,748.07 | 2019-2025 | Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit, Comet |
| Abiomed | $1,231.85 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $460.55 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $307.33 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $247.34 | 2019-2025 | Lifevest |
| Pfizer INC. | $192.27 | 2022-2025 | |
| Acist Medical Systems, INC. | $165.42 | 2022 | |
| Amgen INC. | $164.08 | 2022-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $152.25 | 2019-2025 | Eliquis, Camzyos |
| Siemens Medical Solutions USA, INC. | $151.61 | 2023-2025 | Artis Icono Biplane, Naeotom Alpha |
| Penumbra, INC. | $129.63 | 2025 | Indigo System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $125.12 | 2021-2024 | Gore Cardioform Septal Occluder |
| Medtronic Vascular, INC. | $122.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $108.66 | 2021-2024 | Xarelto |
| Cardiovascular Systems INC. | $89.73 | 2019-2020 | |
| Terumo Medical Corporation | $57.23 | 2019-2023 | Glidesheath Slender |
| Alnylam Pharmaceuticals INC. | $55.85 | 2024-2025 | Onpattro, Amvuttra |
| Bridgebio Pharma, INC. | $54.18 | 2025 | Attruby |
| Sanofi-Aventis U.S. LLC | $47.86 | 2022-2023 | |
| Heartflow, INC. | $37.63 | 2025 | |
| Cardinal Health 200 LLC | $34.83 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $33.94 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $32.80 | 2024 | Assure Wcd |
| Chiesi USA, INC. | $32.12 | 2025 | Kengreal |
| Novo Nordisk INC | $31.57 | 2021-2025 | Wegovy |
| Cleerly, INC. | $28.04 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.74 | 2022-2024 | Jardiance |
| Scpharmaceuticals INC. | $21.35 | 2024 | |
| Daxor Corporation | $20.42 | 2023 | Bva-100 |
| Ge Healthcare | $17.11 | 2024 | |
| Cardiva Medical, INC. | $16.30 | 2024 | Optowire |
| Merck Sharp & Dohme LLC | $13.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.